C. White

Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with response

P. Kipnis, W. M. Lee, L. Comanor, 2007, Journal of viral hepatitis.

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis

D. Kuritzkes, J. Schapiro, J. Polli, 2021, AIDS.

Comparison of Nevirapine- and Efavirenz-Containing Antiretroviral Regimens in Antiretroviral-Naïve Patients: A Cohort Study

P. Keiser, C. White, N. Nassar, 2002, HIV clinical trials.

Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine

J. van Lunzen, Ping Wang, M. Krystal, 2022, Antimicrobial agents and chemotherapy.